Novo Nordisk (NVO.N) shares rose more than 7% in pre-market trading after the FDA approved its weight-loss drug Wegovy oral tablets, which will be available in January next year.

2025-12-23

Novo Nordisk (NVO.N) shares rose more than 7% in pre-market trading after the FDA approved its weight-loss drug Wegovy oral tablets, which will be available in January next year.

Other News
2025-12-23

US President Trump: (Regarding Cambodia and Thailand) I think we're making pretty good progress in that regard.

2025-12-23

Asian Stocks 1. The Shanghai Composite Index closed up 26.92 points, or 0.69%, at 3917.36 on Monday, December 22. 2. The Shenzhen Component Index closed up 192.52 points, or 1.47%, at 13332.73 on Monday, December 22. 3. The CSI 300 Index closed up